Nutchapon Xanthavanij

Nutchapon Xanthavanij

Auto-generated profile, based on publicly available information

Nutchapon Xanthavanij

Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2026 in Annals of Internal Medicine
Verified
Journal Article
Closed access
AKAlbert Ko
Albert Ko
YCYu-Cheng Chang
Yu-Cheng Chang
FBFurkan Bahar
Furkan Bahar
TWTsu Hsien Wang
Tsu Hsien Wang
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
SLShuwen Lin
Shuwen Lin
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used for type 2 diabetes mellitus (T2DM) and overweight or obesity, but their association with cancer is unclear. To investigate the risk for obesity-related cancer associated with GLP-1RAs. PubMed, Embase, Web of Science, Scopus, and the Cochrane Central Register of Controlled Trials from inception to August 2025. Randomized placebo-controlled trials reporting any of the following cancer outcomes: thyroid, pancreatic, colorectal, gastric, esophageal, liver, gallbladder, breast, ovarian, endometrial, or kidney cancer; multiple myeloma; or meningioma. Risk of bias was evaluated using the Cochrane Risk of Bias 2 tool, and certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Odds ratios (ORs) were pooled using random-effects meta-analysis. The review included 48 trials involving 94 245 participants. GLP-1RAs probably have little or no effect on risk for thyroid cancer (OR, 1.37 [95% CI, 0.82 to 2.31]; 1 fewer to 9 more cases per 10 000 patients treated), pancreatic cancer (OR, 0.84 [CI, 0.53 to 1.35]; 9 fewer to 6 more per 10 000), breast cancer (OR, 0.95 [CI, 0.60 to 1.49]; 10 fewer to 12 more per 10 000), or kidney cancer (OR, 1.12 [CI, 0.78 to 1.60]; 5 fewer to 13 more per 10 000) (moderate certainty). GLP-1RAs may have little or no effect on colorectal, esophageal, liver, gallbladder, ovarian, or endometrial cancer; multiple myeloma; or meningioma (low certainty). The effect on gastric cancer is very uncertain. Results were consistent in sensitivity analyses of trials with low risk of bias and studies of semaglutide or tirzepatide and across subgroups stratified by follow-up duration, population, GLP-1RA class, weight loss profile, dose, and duration of action. The included trials were not designed to evaluate cancer outcomes and had short follow-up. GLP-1RAs may have little or no effect on risk for obesity-related cancers. Longer-term studies are needed to clarify potential risks or benefits. None. (PROSPERO: CRD42024608365).

23 June 2023 in Foods
Verified
Journal Article
Open access
PDF file
NJNarachai Julanon
Narachai Julanon
BTBen Thiravetyan
Ben Thiravetyan
Chanita UnhapipatpongChanita Unhapipatpong
Chanita Unhapipatpong
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
TKThanachit Krikeerati
Thanachit Krikeerati
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
This cross-sectional study aimed to investigate the prevalence and clinical characteristics of cross-reactivity and co-allergy to other plant foods among adult patients with IgE-mediated banana allergy in Thailand. A structured questionnaire was used to assess clinical reactivity, and cross-reactivity diagnoses were based on reactions occurring within 2 years of banana allergy onset, within 3 h of intake, and confirmed by allergists. Among the 133 participants, the most commonly associated plant foods with clinical reactions were kiwi (83.5%), avocado (71.1%), persimmon (58.8%), grapes (44.0%), and durian (43.6%). Notably, 26.5% of the reported reactions to other plant foods were classified as severe. These findings highlight the common occurrence of cross-reactivity/co-allergy to other plant foods in banana-allergic patients, with a significant proportion experiencing severe reactions. Travelers to tropical regions should be aware of this risk and advised to avoid specific banana cultivars and plant foods with reported high cross-reactivity. The inclusion of self-injectable epinephrine in the management plan for patients with primary banana allergy should be considered due to the substantial proportion of reported severe reactions and the wide range of clinical cross-reactivity and co-allergy observed.

28 March 2025 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Open access
PDF file
TSThanathip Suenghataiphorn
Thanathip Suenghataiphorn
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
Panat YanpisetPanat Yanpiset
Panat Yanpiset
TSThitiphan Srikulmontri
Thitiphan Srikulmontri
BTBen Thiravetyan
Ben Thiravetyan
PWPhuuwadith Wattanachayakul
Phuuwadith Wattanachayakul
Background and Aims: Constipation is commonly seen among patients with cardiovascular diseases and is linked to adverse outcomes. However, the association between constipation and the risk of acute myocardial infarction (AMI) remains conflicting. Therefore, we aimed to conduct a systematic review and meta-analysis to summarize the available data on this topic. Method: We identified potentially eligible studies from the MEDLINE and EMBASE databases, searching from inception to May 2024, to investigate the association between constipation and the risk of developing AMI. To be included, studies needed to compare incidence of AMI between cohorts with and without constipation. Effect size and 95% confidence intervals (CIs) were combined using the generic inverse variance method. All statistical analyses were performed by Review Manager 5.4. Results: Our meta-analysis included seven studies that met the eligibility criteria. There were 5,351,976 participants, with a mean age of 57.8 years and 74% were males. We found that patients with constipation had a 14% increased risk of AMI with a pooled risk ratio (RR) of 1.14 (95%CI: 1.08-1.14; I²=85%; p<0.001) compared to those without constipation. Conclusions: Our study revealed that constipation is associated with a higher risk of AMI. Emphasizing and addressing gastrointestinal health, including constipation, as an important issue is essential for comprehensive cardiovascular care.

25 September 2024 in Cancer Letters
Verified
Journal Article
Closed access
XXXiaocao “Haze” Xu
Xiaocao “Haze” Xu
JSJunmin Song
Junmin Song
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
KCKuan-Yu Chi
Kuan-Yu Chi
YCYu-Cheng Chang
Yu-Cheng Chang
SLShuwen Lin
Shuwen Lin

30 October 2026 in Foods
Verified
Journal Article
Open access
PDF file
NJNarachai Julanon
Narachai Julanon
BTBen Thiravetyan
Ben Thiravetyan
Chanita UnhapipatpongChanita Unhapipatpong
Chanita Unhapipatpong
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
TKThanachit Krikeerati
Thanachit Krikeerati
MSMongkhon Sompornrattanaphan
Mongkhon Sompornrattanaphan
There was an error in the original publication

9 November 2026 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
Tulaton SodsriTulaton Sodsri
Tulaton Sodsri
NCNattanicha Chaisrimaneepan
Nattanicha Chaisrimaneepan
BTBen Thiravetyan
Ben Thiravetyan
RBRabhas Boonyawairote
Rabhas Boonyawairote
NMNopavit Mohpichai
Nopavit Mohpichai
TPTananchai Petnak
Tananchai Petnak